Clin2
NCT05246163Possibly a fitRecruiting

Smartphone app that helps detect skin cancer

Skin Cancer

Part of Cancer, Skin clinical trials.

This trial tests an artificial-intelligence smartphone app that helps spot possible skin cancer by looking at skin spots (lesions). You may benefit by getting guidance on whether your new or changing mole needs closer attention.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,500 people
Ages
18 years and older
Study type
Observational

Who can take part

  • Be 18 years or older
  • Have 1–2 skin spots to check
  • One of your spots must be new or different in one of these ways: new mole, “ugly duckling” (stands out from your other moles), changing (size/color/shape/feel), rapidly growing, or not healing
  • You must be willing to sign informed consent to join the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06932172Recruiting
AI tool to help diagnose skin cancer in primary care

This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.

Finspång, Docent
NCT05033678Recruiting
Teledermoscopy and AI help review your skin spot images

This study tests a way for doctors to send clear images of your skin spot to be reviewed remotely using teledermoscopy (digital images of the skin). It may help speed up specialist input and improve how skin spots are assessed.

Lund
NCT07349940Recruiting
Early skin cancer detection via telemedicine in primary care

This study tests if a telemedicine tool can help find skin tumors early. It may be a good fit if you have a suspicious spot and light skin that burns easily.

Brno
NCT06064019Recruiting
Using Nevisense to help diagnose skin cancer

This study tests a device called Nevisense that helps doctors check if a suspicious skin spot is a type of skin cancer called keratinocyte cancer (including basal cell carcinoma, squamous cell carcinoma, and related conditions like actinic keratosis). If you have a spot that your doctor is unsure about, this tool may help get a clearer answer.

Wuppertal
NCT07144306Recruiting
AI-powered skin cancer detection study

This trial tests an artificial intelligence system designed to spot skin cancer early. You may be able to join if you are an adult with a suspicious skin spot and can give permission to participate.

London
NCT06724627Recruiting
AI skin check app for walk-in clinic patients

This trial tests a smartphone-based AI system that helps diagnose skin conditions. It may offer faster, more accurate diagnosis for people visiting a walk-in clinic with a skin problem.

The Bronx, New York

Hear when a new Skin Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.